ODEFSEY 25 MG
RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE) : 25 MG TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) : 25 MG EMTRICITABINE : 200 MG · DIN 02461463 · GILEAD SCIENCES CANADA INC
Health Canada status: MARKETED
What is ODEFSEY?
ODEFSEY 25 MG contains RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE) : 25 MG TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) : 25 MG EMTRICITABINE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02461463, held by GILEAD SCIENCES CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 20-Mar-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ODEFSEY used for?
ODEFSEY (emtricitabine [FTC] / rilpivirine [RPV] / tenofovir alafenamide [TAF]) is indicated as a complete regimen for the treatment of adults infected with HIV-1 with no known mutations associated with resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, tenofovir or FTC, and with a viral load ≤ 100,000 copies/mL.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02461463 |
|---|---|
| Brand name | ODEFSEY |
| Generic / active ingredient | RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE) : 25 MG TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) : 25 MG EMTRICITABINE : 200 MG |
| Manufacturer | GILEAD SCIENCES CANADA INC |
| Strength | 25 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AR19 EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND RILPIVIRINE |
| AHFS class | 08:18.08.20 ; 08:18.08.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Mar-2017 |
| Original market date | 2017-03-20 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Each bottle contains 30 tablets
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.